Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight for PXED because its regulated online-education model requires sustained profitability to maintain the Department of Education composite score, operating cash flow to fund dividends and share repurchases, and balance-sheet liquidity to satisfy financial-responsibility standards.

Composite Trajectory: Mixed

The annual income statement shows improvement (revenue +6%, net income +17.6%, margin expansion), but the most recent quarterly and nine-month periods show sharp GAAP earnings deterioration (Q3 net income -28.8%, nine-month net income -45%) driven by IPO-related share-based compensation and one-time charges. Cash flow from operations fell 46% in FY2025 versus FY2024 but rose 125% in the first nine months of FY2026 versus the prior year. The balance sheet contracted in FY2025 (cash and investments -49%, equity -31%) due to large capital distributions, though it has partially recovered in the nine months ended May 2026 (cash and investments +38%, equity +36%). These conflicting directional signals across periods and statements yield a mixed overall trajectory.

2. Red Flags

• GAAP earnings vs. adjusted EBITDA divergence widening: FY2025 net income margin 13.4% vs. adjusted EBITDA margin 24.2% (10-K 2025-08-31, MD&A Key Performance Metrics); Q3 FY2026 net income margin 14.4% vs. adjusted EBITDA margin 28.7% (10-Q 2026-05-31, MD&A Key Performance Metrics). The gap is driven by non-cash share-based compensation ($47.6M in nine months FY2026 vs. $1.9M prior year) and restructuring/strategic charges (10-Q 2026-05-31, Non-GAAP Reconciliations).
• Sharp GAAP earnings decline in interim periods despite flat revenue: Q3 FY2026 net income attributable to Phoenix Education Partners, Inc. fell 27.3% YoY to $39.2M on flat revenue (10-Q 2026-05-31, Condensed Statements of Operations); nine-month net income fell 43.8% to $65.4M on 0.9% revenue growth (10-Q 2026-05-31, Condensed Statements of Operations).
• Large capital distributions depleting cash and equity: FY2025 distributions to limited partners $214.4M and noncontrolling interests $36.2M (10-K 2025-08-31, Consolidated Statements of Cash Flows) reduced total cash, restricted cash, and marketable securities 49% to $194.8M (10-K 2025-08-31, Consolidated Balance Sheets) and turned noncontrolling interest negative (-$6.7M) (10-K 2025-08-31, Consolidated Balance Sheets).
• Rising litigation/regulatory and cybersecurity costs: Nine-month strategic alternatives, restructuring and other expense jumped 77% to $31.7M, including $5.1M cybersecurity incident and $7.4M litigation/regulatory charges (10-Q 2026-05-31, Note 2).
• Accounts receivable surge with high allowance: Nine-month accounts receivable net increased 64% to $96.5M (10-Q 2026-05-31, Condensed Balance Sheets) while allowance for credit losses remains ~46% of gross student receivables (10-Q 2026-05-31, Note 5).
• Regulatory concentration risk: 90/10 rule at 88.6% in FY2025 (10-K 2025-08-31, Note 14) and composite score 2.6 (10-K 2025-08-31, Note 14) leave limited buffer.

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results improved: FY2025 net revenue rose 6.0% to $1,007.2M, operating income rose 13.3% to $172.1M, and net income attributable to the Company rose 18.3% to $133.9M, with net income margin expanding from 12.1% to 13.4% (10-K 2025-08-31, Consolidated Statements of Income). However, the most recent comparable interim periods deteriorated sharply: Q3 FY2026 net revenue was flat at $271.8M, operating income fell 27.1% to $51.8M, and net income attributable to the Company fell 27.3% to $39.2M, compressing margin from 19.8% to 14.4% (10-Q 2026-05-31, Condensed Statements of Operations). Nine-month FY2026 net revenue grew only 0.9% to $756.3M while operating income dropped 39.2% to $91.4M and net income attributable to the Company fell 43.8% to $65.4M, margin contracting from 15.5% to 8.6% (10-Q 2026-05-31, Condensed Statements of Operations). The interim decline is primarily attributable to a $36.0M increase in share-based compensation (nine months) and higher strategic/restructuring charges (10-Q 2026-05-31, MD&A General and administrative; Note 2). Adjusted EBITDA margin remained stable (24.8% to 24.9% nine months; 30.7% to 28.7% Q3) (10-Q 2026-05-31, Non-GAAP Reconciliations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Full-year operating cash flow declined 46% to $87.4M in FY2025 from $163.2M in FY2024, driven by a $163.9M negative working capital swing (mainly a $72.8M drop in student deposits and $55.4M rise in receivables) (10-K 2025-08-31, Consolidated Statements of Cash Flows). In contrast, nine-month FY2026 operating cash flow more than doubled to $116.7M from $51.8M in the prior year, as working capital outflows moderated to $50.1M (vs. $154.6M) despite a $62.1M receivables increase, offset by a $38.8M deferred revenue inflow (10-Q 2026-05-31, Condensed Statements of Cash Flows). Investing cash outflows surged to $104.7M in nine months FY2026 (from $15.8M) due to $89.5M net marketable securities purchases (10-Q 2026-05-31, Condensed Statements of Cash Flows). Financing outflows dropped to $27.0M (from $148.7M) as large partner distributions ceased and were replaced by $17.4M dividends, $6.2M share-based award tax withholdings, and $4.0M share repurchases (10-Q 2026-05-31, Condensed Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

The only comparable year-over-year balance sheet (August 31, 2025 vs. August 31, 2024) shows contraction: total assets fell 29% to $493.6M from $695.3M, cash/restricted cash/marketable securities fell 49% to $194.8M from $382.9M, and total equity fell 31% to $240.1M from $348.9M, while noncontrolling interest swung to -$6.7M from +$21.6M (10-K 2025-08-31, Consolidated Balance Sheets). The decline was driven by $250.6M of capital distributions (10-K 2025-08-31, Consolidated Statements of Cash Flows). Liabilities also decreased 27% to $253.5M from $346.3M, primarily from reduced student deposits (-$72.8M) and operating lease liabilities (10-K 2025-08-31, Consolidated Balance Sheets). The sequential (non-YoY) comparison to May 31, 2026 shows recovery (assets +23%, cash/investments +38%, equity +36%, noncontrolling interest +$2.2M) (10-Q 2026-05-31, Condensed Balance Sheets), but no same-quarter prior-year balance sheet is available for a YoY quarterly trend.

6. Data Gaps

• Q1 and Q2 FY2026 standalone income statements and cash flow statements (only nine-month aggregates provided in 10-Q 2026-05-31).
• May 31, 2025 balance sheet for YoY quarterly balance sheet comparison.
• Full FY2026 results (only nine months available).
• Quarterly breakdown of revenue by student type (degree vs. non-degree, employer-sponsored vs. direct) beyond the employer percentage disclosed in MD&A.
• Detailed course-level economics (price per course, courses per student) to assess unit economics trends.
• FY2024 quarterly data for quarterly YoY comparisons prior to Q3 FY2025.